NCT05557526 Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation
| NCT ID | NCT05557526 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Evangelical Hospital Düsseldorf |
| Condition | Atrial Fibrillation |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-06-09 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-06-09 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).
Eligibility Criteria
Inclusion Criteria: * symptomatic atrial fibrillation * indication for pulmonary vein isolation * sufficient command of the German language Exclusion Criteria: * age \<18 years * permanent atrial fibrillation * presence of psychiatric disorders which impair the study participitatin * presence of another medical condiction which influences quality of life stronger than the cardiac condition * atrial fibrillation induced by intoxication, medicamentation or infection * inability to grap the course of the study
Frequently Asked Questions
Who can join the NCT05557526 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05557526 currently recruiting?
Yes, NCT05557526 is actively recruiting participants. Visit ClinicalTrials.gov or contact Evangelical Hospital Düsseldorf to inquire about joining.
Where is the NCT05557526 trial being conducted?
This trial is being conducted at Düsseldorf, Germany, Essen, Germany.
Who is sponsoring the NCT05557526 clinical trial?
NCT05557526 is sponsored by Evangelical Hospital Düsseldorf. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.